LARYNGEAL SQUAMOUS CELL CARCINOMA

LARYNGEAL SQUAMOUS CELL CARCINOMA was reported 108 times

LARYNGEAL SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 2 0.0004
1 Hedgehog Pathway Inhibitor [EPC] 1 0.0001
2 Antifibrinolytic Agent [EPC] 1 0.0001
3 Anti-anginal [EPC] 1 0.0001
4 Interleukin-17A Antagonist [EPC] 3 0.0001
5 Melatonin Receptor Agonist [EPC] 1 0.0001
6 Provitamin D2 Compound [EPC] 2 0.0001
7 Interleukin-23 Antagonist [EPC] 7 0.0001
8 Human Immunoglobulin G [EPC] 1 0.0000
9 Integrin Receptor Antagonist [EPC] 3 0.0000
10 Cholinergic Nicotinic Agonist [EPC] 2 0.0000
11 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
12 Interleukin-12 Antagonist [EPC] 3 0.0000
13 Alkylating Drug [EPC] 7 0.0000
14 Antirheumatic Agent [EPC] 3 0.0000
15 Polyene Antifungal [EPC] 1 0.0000
16 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
17 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
18 Purine Antimetabolite [EPC] 2 0.0000
19 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
20 Opioid Agonist [EPC] 5 0.0000
21 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
22 Complement Inhibitor [EPC] 1 0.0000
23 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
24 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
25 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
26 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
28 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
29 alpha-Adrenergic Blocker [EPC] 2 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 14 0.0000
31 Leukocyte Growth Factor [EPC] 2 0.0000
32 Proton Pump Inhibitor [EPC] 8 0.0000
33 Androgen Receptor Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 16 0.0000
35 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
36 Thalidomide Analog [EPC] 6 0.0000
37 Platinum-based Drug [EPC] 3 0.0000
38 Factor Xa Inhibitor [EPC] 3 0.0000
39 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
40 Prostaglandin Analog [EPC] 1 0.0000
41 Platelet Aggregation Inhibitor [EPC] 6 0.0000
42 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
43 Aminosalicylate [EPC] 1 0.0000
44 beta-Adrenergic Blocker [EPC] 3 0.0000
45 Sulfonylurea [EPC] 1 0.0000
46 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
47 Fluoroquinolone Antibacterial [EPC] 1 0.0000
48 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
49 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
50 Vitamin C [EPC] 3 0.0000
51 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
52 Osmotic Laxative [EPC] 2 0.0000
53 Calcium [EPC] 1 0.0000
54 Azole Antifungal [EPC] 1 0.0000
55 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
56 Janus Kinase Inhibitor [EPC] 1 0.0000
57 Nonsteroidal Anti-inflammatory Drug [EPC] 8 0.0000
58 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
59 Kinase Inhibitor [EPC] 3 0.0000
60 Interferon beta [EPC] 1 0.0000
61 Thiazide Diuretic [EPC] 1 0.0000
62 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
63 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
64 Vitamin D [EPC] 1 0.0000
65 Vitamin B12 [EPC] 1 0.0000
66 GLP-1 Receptor Agonist [EPC] 1 0.0000
67 Insulin Analog [EPC] 1 0.0000
68 Loop Diuretic [EPC] 1 0.0000
69 Benzodiazepine [EPC] 1 0.0000